$12.28
0.151.26%
Last update: Oct 23, 3:30 PM
BAVARIAN NORDIC R/I S/ADR by Bavarian Nordic A/S (BVNRY) Stock Price, Quote, News & History
BVNRYOTCPK
Moderna is conducting a Phase 1/2 trial of mRNA-1769, a potential mpox vaccine for adults. Early research shows it may outperform Bavarian Nordic's Jynneos in...
You can purchase shares of BAVARIAN NORDIC R/I S/ADR by Bavarian Nordic A/S (OTCPK:BVNRY) through any online brokerage.
There are no as such competitors for BAVARIAN NORDIC R/I S/ADR by Bavarian Nordic A/S.
There is no analysis for BAVARIAN NORDIC R/I S/ADR by Bavarian Nordic A/S to provide a consensus price target.
The stock price for BAVARIAN NORDIC R/I S/ADR by Bavarian Nordic A/S (OTCPK: BVNRY) is $12.28 last updated October 23, 2026 at 3:30 PM EDT.
There are no upcoming dividends for BAVARIAN NORDIC R/I S/ADR by Bavarian Nordic A/S.
BAVARIAN NORDIC R/I S/ADR by Bavarian Nordic A/S does not have any upcoming earnings scheduled.
There is no upcoming split for BAVARIAN NORDIC R/I S/ADR by Bavarian Nordic A/S.
BAVARIAN NORDIC R/I S/ADR by Bavarian Nordic A/S is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.
Bavarian Nordic AS is a biotechnology company focused on the research, development, manufacturing, and commercialization of life-saving vaccines. The group is a supplier of mpox and smallpox vaccines to governments to enhance public health...
